Alkermes PLC Company Profile (NASDAQ:ALKS)

About Alkermes PLC

Alkermes PLC logoAlkermes Public Limited Company is a biopharmaceutical company. The Company is engaged in researching, developing and commercializing, both with partners and on its own, pharmaceutical products that are designed to address medical needs of patients in therapeutic areas. The Company has a portfolio of approximately 20 products and a clinical pipeline of product candidates that address central nervous system (CNS) disorders, such as schizophrenia, depression, addiction and multiple sclerosis. Its products include ARISTADA, VIVITROL, RISPERDAL CONSTA, INVEGA SUSTENNA/XEPLION & INVEGA TRINZA, AMPYRA/FAMPYRA, BYDUREON, ALKS 5461, ALKS 3831, ALKS 8700, ALKS 6428, Aripiprazole Lauroxil Two-Month Dose, ALKS 7119 and RDB 1450. Its product platforms include injectable extended-release microsphere technology, LinkeRx technology, NanoCrystal technology and oral controlled release technology.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Drug Delivery
  • Sub-Industry: Biotechnology
  • Exchange: NASDAQ
  • Symbol: ALKS
  • CUSIP: G0176710
Key Metrics:
  • Previous Close: $48.58
  • 50 Day Moving Average: $46.784
  • 200 Day Moving Average: $42.977
  • 52-Week Range: $27.14 - $80.71
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: 131.03
  • P/E Growth: 14.250
  • Market Cap: $7.52B
  • Outstanding Shares: 151,556,000
  • Beta: 2.04
Profitability:
  • Net Margins: -41.19%
  • Return on Equity: -14.18%
  • Return on Assets: -10.06%
Debt:
  • Debt-to-Equity Ratio: 0.23%
  • Current Ratio: 3.93%
  • Quick Ratio: 3.72%
Additional Links:
Companies Related to Alkermes PLC:

Analyst Ratings

Consensus Ratings for Alkermes PLC (NASDAQ:ALKS) (?)
Ratings Breakdown: 1 Sell Rating, 3 Hold Ratings, 6 Buy Ratings
Consensus Rating:Buy (Score: 2.50)
Consensus Price Target: $55.67 (11.80% upside)

Analysts' Ratings History for Alkermes PLC (NASDAQ:ALKS)
Show:
DateFirmActionRatingPrice TargetDetails
9/27/2016Citigroup Inc.Boost Price TargetNeutral$44.00 -> $53.00View Rating Details
9/23/2016Cowen and CompanyReiterated RatingBuyView Rating Details
9/2/2016Morgan StanleyReiterated RatingSell$41.00View Rating Details
7/29/2016JPMorgan Chase & Co.Reiterated RatingHold$51.00View Rating Details
7/29/2016Jefferies GroupBoost Price TargetBuy$54.00 -> $62.00View Rating Details
7/29/2016Barclays PLCBoost Price TargetOverweight$65.00 -> $66.00View Rating Details
6/28/2016Leerink SwannReiterated RatingOutperform$58.00 -> $54.00View Rating Details
6/2/2016Credit Suisse Group AGReiterated RatingBuyView Rating Details
5/26/2016Evercore ISIInitiated CoverageBuy$59.00View Rating Details
2/22/2016Goldman Sachs Group Inc.Lower Price Target$57.00 -> $35.00View Rating Details
1/21/2016GuggenheimReiterated RatingHoldView Rating Details
2/25/2015Bank of America Corp.Set Price TargetSell$45.00View Rating Details
1/8/2015MizuhoBoost Price TargetBuy$72.00 -> $81.00View Rating Details
(Data available from 9/28/2014 forward)

Earnings

Earnings History for Alkermes PLC (NASDAQ:ALKS)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
10/27/2016        
7/28/2016Q216($0.10)($0.01)$174.15 million$195.20 millionViewListenView Earnings Details
4/28/2016Q116($0.20)($0.16)$153.64 million$156.80 millionViewListenView Earnings Details
2/25/2016Q415($0.18)($0.15)$161.24 million$163.10 millionViewListenView Earnings Details
10/29/2015Q315($0.21)($0.18)$151.77 million$152.70 millionViewListenView Earnings Details
7/30/2015Q215($0.10)($0.09)$142.80 million$151.40 millionViewListenView Earnings Details
4/30/2015Q115($0.03)$0.06$146.60 million$161.20 millionViewListenView Earnings Details
2/24/2015Q414$0.04$0.11$161.70 million$175.20 millionViewListenView Earnings Details
10/29/2014Q314$0.02$0.03$155.53 million$160.00 millionViewListenView Earnings Details
7/31/2014Q314$0.14$0.11$146.91 million$153.40 millionViewListenView Earnings Details
4/30/2014Q1$0.10$0.11$135.79 million$130.21 millionViewListenView Earnings Details
2/27/2014Q114$0.20$0.27$142.93 million$154.50 millionViewListenView Earnings Details
10/31/2013$0.22$0.22$137.35 million$139.80 millionViewListenView Earnings Details
7/25/2013Q1 2014$0.22$0.30$131.50 million$138.60 millionViewListenView Earnings Details
5/23/2013Q4 2013$0.17$0.40$128.01 million$163.40 millionViewListenView Earnings Details
1/31/2013Q3 2013$0.23$0.34$130.81 million$135.90 millionViewListenView Earnings Details
11/1/2012Q213$0.11$0.17$121.62 million$124.00 millionViewN/AView Earnings Details
7/26/2012$0.16$0.39ViewN/AView Earnings Details
5/17/2012($0.16)($0.14)ViewN/AView Earnings Details
2/2/2012($0.21)($0.11)ViewN/AView Earnings Details
11/3/2011($0.10)($0.22)ViewN/AView Earnings Details
8/1/2011($0.11)$0.02ViewN/AView Earnings Details
5/18/2011($0.14)($0.14)ViewN/AView Earnings Details
2/3/2011($0.15)($0.06)ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Alkermes PLC (NASDAQ:ALKS)
Current Year EPS Consensus Estimate: $-0.12 EPS
Next Year EPS Consensus Estimate: $0.38 EPS
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q2 20161($0.16)($0.16)($0.16)
(Data provided by Zacks Investment Research)

Dividends

Dividend History for Alkermes PLC (NASDAQ:ALKS)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Alkermes PLC (NASDAQ:ALKS)
Insider Ownership Percentage: 4.75%
Institutional Ownership Percentage: 95.13%
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
9/22/2016Elliot EhrichCMOSell5,000$50.83$254,150.00View SEC Filing  
9/16/2016Elliot EhrichCMOSell5,000$48.87$244,350.00View SEC Filing  
9/6/2016David Joseph GaffinSVPSell2,382$45.92$109,381.44View SEC Filing  
9/6/2016Elliot EhrichCMOSell10,000$46.02$460,200.00View SEC Filing  
9/6/2016Iain Michael BrownCAOSell29,976$45.92$1,376,497.92View SEC Filing  
9/6/2016Paul J MitchellDirectorSell2,000$45.92$91,840.00View SEC Filing  
8/4/2016Paul J MitchellDirectorSell2,000$49.48$98,960.00View SEC Filing  
7/27/2016Elliot EhrichCMOSell35,199$51.95$1,828,588.05View SEC Filing  
7/5/2016Paul J MitchellDirectorSell2,000$45.81$91,620.00View SEC Filing  
6/6/2016Paul J MitchellDirectorSell2,000$44.98$89,960.00View SEC Filing  
5/4/2016Paul J MitchellDirectorSell2,000$38.60$77,200.00View SEC Filing  
4/20/2016Michael J LandineSVPSell16,875$41.09$693,393.75View SEC Filing  
4/19/2016Richard F PopsCEOSell18,750$40.15$752,812.50View SEC Filing  
4/18/2016Iain Michael BrownCAOSell5,368$39.27$210,801.36View SEC Filing  
4/13/2016Elliot EhrichCMOSell11,698$37.66$440,546.68View SEC Filing  
4/12/2016Richard F PopsCEOSell25,000$37.79$944,750.00View SEC Filing  
4/4/2016Paul J MitchellDirectorSell2,000$35.65$71,300.00View SEC Filing  
3/22/2016Richard F PopsCEOSell25,000$31.77$794,250.00View SEC Filing  
3/15/2016Richard F PopsCEOSell25,000$31.40$785,000.00View SEC Filing  
3/4/2016Paul J MitchellDirectorSell2,000$32.80$65,600.00View SEC Filing  
3/3/2016David W AnsticeDirectorBuy5,000$32.87$164,350.00View SEC Filing  
2/4/2016Paul J. MitchellDirectorSell2,000$32.81$65,620.00View SEC Filing  
1/4/2016Robert A BreyerDirectorSell2,000$77.33$154,660.00View SEC Filing  
12/28/2015Mark StejbachinsiderSell10,000$80.24$802,400.00View SEC Filing  
12/23/2015Shane CookeinsiderSell18,000$77.23$1,390,140.00View SEC Filing  
12/7/2015Michael J. LandineSVPSell3,750$73.02$273,825.00View SEC Filing  
12/7/2015Richard F. PopsCEOSell37,500$72.06$2,702,250.00View SEC Filing  
12/1/2015Mark StejbachinsiderSell18,000$72.18$1,299,240.00View SEC Filing  
12/1/2015Michael J. LandineSVPSell10,000$72.18$721,800.00View SEC Filing  
12/1/2015Richard F. PopsCEOSell50,000$72.29$3,614,500.00View SEC Filing  
12/1/2015Robert A BreyerDirectorSell2,000$73.46$146,920.00View SEC Filing  
11/23/2015Shane CookeinsiderSell18,000$72.62$1,307,160.00View SEC Filing  
11/2/2015Mark StejbachinsiderSell18,000$72.06$1,297,080.00View SEC Filing  
11/2/2015Robert A BreyerDirectorSell2,000$71.80$143,600.00View SEC Filing  
10/29/2015Iain Michael BrownCAOSell10,822$69.99$757,431.78View SEC Filing  
10/23/2015Shane CookeinsiderSell18,000$62.03$1,116,540.00View SEC Filing  
10/13/2015James M. FratesCFOSell20,000$59.78$1,195,600.00View SEC Filing  
10/2/2015Robert A. BreyerDirectorSell2,000$60.00$120,000.00View SEC Filing  
9/23/2015Shane CookeinsiderSell18,000$67.09$1,207,620.00View SEC Filing  
9/17/2015Michael J. LandineSVPSell10,000$71.20$712,000.00View SEC Filing  
9/17/2015Richard F. PopsCEOSell50,000$71.27$3,563,500.00View SEC Filing  
9/15/2015James M. FratesCFOSell20,000$71.10$1,422,000.00View SEC Filing  
9/10/2015Michael J. LandineSVPSell10,000$67.61$676,100.00View SEC Filing  
9/10/2015Richard F. PopsCEOSell50,000$67.57$3,378,500.00View SEC Filing  
9/1/2015Robert A BreyerDirectorSell2,000$61.43$122,860.00View SEC Filing  
8/24/2015Shane CookeinsiderSell18,000$57.65$1,037,700.00View SEC Filing  
7/23/2015Shane CookeInsiderSell18,000$69.79$1,256,220.00View SEC Filing  
7/20/2015Gordon G PughCOOSell18,750$70.10$1,314,375.00View SEC Filing  
7/14/2015James M FratesCFOSell20,000$65.79$1,315,800.00View SEC Filing  
7/1/2015Gordon G PughCOOSell13,750$65.13$895,537.50View SEC Filing  
7/1/2015Robert A BreyerDirectorSell2,000$64.90$129,800.00View SEC Filing  
6/23/2015Shane CookeInsiderSell18,000$66.84$1,203,120.00View SEC Filing  
6/17/2015Paul J MitchellDirectorSell15,500$65.10$1,009,050.00View SEC Filing  
6/16/2015Gordon G PughCOOSell32,977$63.11$2,081,178.47View SEC Filing  
6/16/2015James M FratesCFOSell10,000$58.63$586,300.00View SEC Filing  
6/1/2015Paul J MitchellDirectorSell1,500$60.78$91,170.00View SEC Filing  
6/1/2015Rebecca PetersonSVPSell21,983$60.05$1,320,079.15View SEC Filing  
5/26/2015Rebecca PetersonSVPSell1,322$60.49$79,967.78View SEC Filing  
5/26/2015Shane CookeInsiderSell18,000$60.31$1,085,580.00View SEC Filing  
5/22/2015Rebecca PetersonSVPSell28,558$61.71$1,762,314.18View SEC Filing  
5/12/2015James M FratesCFOSell10,000$59.34$593,400.00View SEC Filing  
5/4/2015Robert A BreyerDirectorSell2,000$60.00$120,000.00View SEC Filing  
5/1/2015Paul J MitchellDirectorSell1,500$55.79$83,685.00View SEC Filing  
4/23/2015Shane CookeInsiderSell18,000$62.55$1,125,900.00View SEC Filing  
4/21/2015Elliot EhrichCMOSell25,000$62.39$1,559,750.00View SEC Filing  
4/15/2015Gordon G PughCOOSell13,750$63.21$869,137.50View SEC Filing  
4/15/2015James M FratesCFOSell10,000$62.42$624,200.00View SEC Filing  
4/15/2015Paul J MitchellDirectorSell1,500$62.71$94,065.00View SEC Filing  
4/1/2015Robert A BreyerDirectorSell5,000$61.22$306,100.00View SEC Filing  
3/23/2015Shane CookeInsiderSell18,000$65.33$1,175,940.00View SEC Filing  
3/16/2015Elliot EhrichCMOSell18,000$66.81$1,202,580.00View SEC Filing  
3/10/2015James M FratesCFOSell10,000$66.25$662,500.00View SEC Filing  
3/5/2015Rebecca PetersonSVPSell17,737$71.37$1,265,889.69View SEC Filing  
3/2/2015Gordon G PughCOOSell15,000$71.39$1,070,850.00View SEC Filing  
3/2/2015Robert A BreyerDirectorSell5,000$70.86$354,300.00View SEC Filing  
2/23/2015Shane CookeInsiderSell18,000$74.29$1,337,220.00View SEC Filing  
2/17/2015Elliot EhrichCMOSell18,000$70.87$1,275,660.00View SEC Filing  
2/3/2015James M FratesCFOSell10,000$70.83$708,300.00View SEC Filing  
2/2/2015Gordon G PughCOOSell15,000$72.01$1,080,150.00View SEC Filing  
2/2/2015Robert A BreyerDirectorSell5,000$72.91$364,550.00View SEC Filing  
1/26/2015Gordon G PughCOOSell15,000$70.02$1,050,300.00View SEC Filing  
1/23/2015Shane CookeInsiderSell118,000$69.13$8,157,340.00View SEC Filing  
1/16/2015Floyd E BloomDirectorSell20,000$67.12$1,342,400.00View SEC Filing  
1/15/2015Elliot EhrichCMOSell18,375$66.45$1,221,018.75View SEC Filing  
1/15/2015James M FratesCFOSell10,000$66.86$668,600.00View SEC Filing  
1/7/2015Kathryn L BibersteinSVPSell28,374$65.00$1,844,310.00View SEC Filing  
1/2/2015Robert A BreyerDirectorSell5,000$58.57$292,850.00View SEC Filing  
12/11/2014Richard F PopsCEOSell100,000$56.04$5,604,000.00View SEC Filing  
12/10/2014James M FratesCFOSell18,870$56.07$1,058,040.90View SEC Filing  
12/9/2014Michael J LandineSVPSell18,000$56.82$1,022,760.00View SEC Filing  
12/5/2014Kathryn L BibersteinSVPSell15,433$57.61$889,095.13View SEC Filing  
12/1/2014Robert A BreyerDirectorSell5,000$54.64$273,200.00View SEC Filing  
11/19/2014James M FratesCFOSell8,000$53.86$430,880.00View SEC Filing  
11/13/2014Richard F PopsCEOSell100,000$52.87$5,287,000.00View SEC Filing  
11/7/2014James M FratesCFOSell13,303$49.98$664,883.94View SEC Filing  
11/6/2014Kathryn L BibersteinSVPSell20,000$50.54$1,010,800.00View SEC Filing  
11/3/2014Robert A BreyerDirectorSell5,000$50.05$250,250.00View SEC Filing  
10/23/2014Gordon G PughCOOSell14,577$45.00$655,965.00View SEC Filing  
10/8/2014James M FratesCFOSell16,000$41.00$656,000.00View SEC Filing  
10/1/2014Robert A BreyerDirectorSell5,000$42.59$212,950.00View SEC Filing  
9/24/2014James M FratesCFOSell16,000$45.29$724,640.00View SEC Filing  
9/18/2014Michael J LandineSVPSell15,000$45.60$684,000.00View SEC Filing  
9/17/2014Gordon G PughCOOSell14,900$45.04$671,096.00View SEC Filing  
9/17/2014Richard F PopsCEOSell50,000$44.89$2,244,500.00View SEC Filing  
9/10/2014James M FratesCFOSell16,000$43.18$690,880.00View SEC Filing  
9/2/2014Gordon G PughCOOSell1,100$45.08$49,588.00View SEC Filing  
9/2/2014Robert A BreyerDirectorSell5,000$45.12$225,600.00View SEC Filing  
8/27/2014James M FratesCFOSell16,000$45.08$721,280.00View SEC Filing  
8/26/2014Gordon G PughCOOSell16,000$45.00$720,000.00View SEC Filing  
8/13/2014James M FratesCFOSell15,000$41.37$620,550.00View SEC Filing  
8/11/2014Elliot EhrichCMOSell16,667$41.65$694,180.55View SEC Filing  
8/4/2014Gordon G PughCOOSell23,250$43.20$1,004,400.00View SEC Filing  
8/1/2014Robert A BreyerDirectorSell5,000$42.53$212,650.00View SEC Filing  
7/16/2014James M FratesCFOSell8,000$46.50$372,000.00View SEC Filing  
7/9/2014Elliot EhrichCMOSell16,667$47.41$790,182.47View SEC Filing  
7/9/2014James M FratesCFOSell7,000$47.41$331,870.00View SEC Filing  
7/3/2014Michael J LandineSVPSell7,000$51.31$359,170.00View SEC Filing  
7/2/2014Richard F PopsCEOSell50,000$51.69$2,584,500.00View SEC Filing  
7/1/2014Gordon G PughCOOSell16,000$46.49$743,840.00View SEC Filing  
7/1/2014Robert A BreyerDirectorSell5,000$50.57$252,850.00View SEC Filing  
6/26/2014Michael J LandineSVPSell10,000$49.92$499,200.00View SEC Filing  
6/25/2014James M FratesCFOSell7,000$50.22$351,540.00View SEC Filing  
6/25/2014Richard F PopsCEOSell50,000$49.87$2,493,500.00View SEC Filing  
6/20/2014Paul J MitchellDirectorSell17,000$50.00$850,000.00View SEC Filing  
6/19/2014Elliot EhrichCMOSell17,282$47.10$813,982.20View SEC Filing  
6/19/2014Michael J LandineSVPSell10,000$47.01$470,100.00View SEC Filing  
6/18/2014Richard F PopsCEOSell50,000$46.72$2,336,000.00View SEC Filing  
6/17/2014Kathryn L BibersteinSVPSell8,400$47.41$398,244.00View SEC Filing  
6/11/2014James M FratesCFOSell7,000$47.72$334,040.00View SEC Filing  
6/9/2014Elliot EhrichCMOSell16,667$48.15$802,516.05View SEC Filing  
6/2/2014Gordon G PughCOOSell16,000$45.34$725,440.00View SEC Filing  
6/2/2014Robert A BreyerDirectorSell5,000$45.18$225,900.00View SEC Filing  
5/30/2014Rebecca PetersonSVPSell21,981$45.86$1,008,048.66View SEC Filing  
5/23/2014Rebecca PetersonSVPSell1,321$45.08$59,550.68View SEC Filing  
5/22/2014Elliot EhrichCMOSell2,378$44.49$105,797.22View SEC Filing  
5/22/2014Gordon PughCOOSell15,700$45.25$710,425.00View SEC Filing  
5/22/2014Rebecca PetersonSVPSell19,807$44.02$871,904.14View SEC Filing  
5/21/2014Elliot EhrichCMOSell1,981$44.00$87,164.00View SEC Filing  
5/21/2014James FratesCFOSell7,000$44.30$310,100.00View SEC Filing  
5/20/2014Rebecca PetersonSVPSell20,307$44.05$894,523.35View SEC Filing  
5/19/2014Elliot EhrichCMOSell2,206$43.55$96,071.30View SEC Filing  
5/8/2014Floyd BloomDirectorSell10,000$46.16$461,600.00View SEC Filing  
5/5/2014Robert BreyerDirectorSell5,000$46.72$233,600.00View SEC Filing  
5/1/2014Paul MitchellDirectorSell1,000$45.90$45,900.00View SEC Filing  
4/9/2014James FratesCFOSell7,000$42.91$300,370.00View SEC Filing  
4/1/2014Paul MitchellDirectorSell1,500$44.14$66,210.00View SEC Filing  
3/19/2014James FratesCFOSell7,000$46.84$327,880.00View SEC Filing  
3/11/2014Wendy DixonDirectorBuy1,600$47.37$75,792.00View SEC Filing  
3/5/2014James FratesCFOSell7,000$47.78$334,460.00View SEC Filing  
2/18/2014Elliot EhrichCMOSell7,718$52.45$404,809.10View SEC Filing  
2/3/2014Paul MitchellDirectorSell1,500$48.15$72,225.00View SEC Filing  
1/21/2014Elliot EhrichCMOSell7,718$48.61$375,171.98View SEC Filing  
1/16/2014Elliot EhrichCMOSell14,555$47.35$689,179.25View SEC Filing  
1/16/2014Gordon PughCOOSell30,000$47.16$1,414,800.00View SEC Filing  
1/16/2014James FratesCFOSell7,000$47.40$331,800.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for Alkermes PLC (NASDAQ:ALKS)
DateHeadline
fidaily.com logoAlkermes plc (ALKS) - Citigroup Maintains Rating And Lowers Price Target - Finance Daily (NASDAQ:ALKS)
www.fidaily.com - September 27 at 3:27 PM
finance.yahoo.com logoCramer's Stop Trading: GILD, GWPH & ALKS (NASDAQ:ALKS)
finance.yahoo.com - September 27 at 3:27 PM
thestreet.com logoJim Cramer -- Gilead Needs to Make an Acquisition (NASDAQ:ALKS)
www.thestreet.com - September 27 at 3:27 PM
investors.com logoVirgin Extends Drop As Alaska Air Merger Review Grows Longer (NASDAQ:ALKS)
www.investors.com - September 23 at 3:52 PM
fidaily.com logoAlkermes plc (NASDAQ:ALKS) Trading Up – Insiders Selling, Short Interest Growing (NASDAQ:ALKS)
www.fidaily.com - September 23 at 8:15 AM
News IconTop Earnings to Watch for: Alkermes plc (NASDAQ:ALKS) - The Voice Registrar (NASDAQ:ALKS)
voiceregistrar.com - September 22 at 9:18 AM
biz.yahoo.com logoALKERMES PLC. Files SEC form 8-K/A, Change in Directors or Principal Officers (NASDAQ:ALKS)
biz.yahoo.com - September 21 at 9:34 AM
publicnow.com logoAlkermes Announces Webcast of Analyst and Investor Event on September 26, 2016 (NASDAQ:ALKS)
www.publicnow.com - September 19 at 4:23 PM
News IconLooking Ahead for Alkermes plc (NASDAQ:ALKS); Are These Shares Ready to Go Higher? - Frisco Fastball (NASDAQ:ALKS)
friscofastball.com - September 18 at 3:23 PM
News IconWhat is the Sell-side Saying About Alkermes plc (NASDAQ:ALKS)? - Frisco Fastball (NASDAQ:ALKS)
friscofastball.com - September 16 at 3:26 PM
News IconStock Seeing Accelerated Sales Growth Quarter over Quarter: Alkermes plc (NASDAQ:ALKS) - Post News (NASDAQ:ALKS)
www.kentuckypostnews.com - September 15 at 8:36 PM
finance.yahoo.com logoMoving Average Crossover Alert: Alkermes (ALKS) (NASDAQ:ALKS)
finance.yahoo.com - September 15 at 12:21 PM
News IconSell-side is Weighing in on Alkermes plc (NASDAQ:ALKS) Earnings - Frisco Fastball (NASDAQ:ALKS)
friscofastball.com - September 14 at 8:43 PM
News IconAlkermes Plc Ord (NASDAQ:ALKS) Short Interest Increased By 11.15% - Frisco Fastball (NASDAQ:ALKS)
friscofastball.com - September 14 at 3:27 PM
News IconShares Holding Above Moving Averages: Alkermes plc (NASDAQ:ALKS) - Post News (NASDAQ:ALKS)
www.kentuckypostnews.com - September 14 at 3:27 PM
investornewswire.com logoCan Shares Of Alkermes plc (NASDAQ:ALKS) Hit $66 - Investor Newswire (NASDAQ:ALKS)
www.investornewswire.com - September 13 at 3:26 PM
News IconShares Gapping Lower Before the Bell: Alkermes plc (NASDAQ:ALKS) - Post News (NASDAQ:ALKS)
www.kentuckypostnews.com - September 12 at 3:26 PM
News IconStock Trading Above Moving Averages: Alkermes plc (NASDAQ:ALKS) - Post News (NASDAQ:ALKS)
www.kentuckypostnews.com - September 12 at 3:26 PM
thestreet.com logoALKERMES™ Inspiration Grants Application (NASDAQ:ALKS)
www.thestreet.com - September 12 at 8:14 AM
publicnow.com logoAlkermes Launches Competitive Grants Program to Support People Affected by Mental Health and Substance Use Disorders (NASDAQ:ALKS)
www.publicnow.com - September 12 at 8:14 AM
investornewswire.com logoEarnings Surprise In Focus: Alkermes plc (NASDAQ:ALKS) - Investor Newswire (NASDAQ:ALKS)
www.investornewswire.com - September 10 at 8:12 AM
seekingalpha.com logoAlkermes Injectable Technologies In Schizophrenia Will Improve Its ... - Seeking Alpha (NASDAQ:ALKS)
seekingalpha.com - September 10 at 8:12 AM
capitalcube.com logoAlkermes Plc – Value Analysis (NASDAQ:ALKS) : September 9, 2016 (NASDAQ:ALKS)
www.capitalcube.com - September 9 at 3:25 PM
News IconPlacing Alkermes plc (NASDAQ:ALKS) Shares Under the Microscope - Post News (NASDAQ:ALKS)
www.kentuckypostnews.com - September 8 at 3:25 PM
capitalcube.com logoAlkermes Plc breached its 50 day moving average in a Bullish Manner : ALKS-US : September 8, 2016 (NASDAQ:ALKS)
www.capitalcube.com - September 8 at 11:34 AM
News IconAlkermes PLC (NASDAQ: ALKS) Stock Rating Reiterated at Morgan Stanley - BNB Daily (blog) (NASDAQ:ALKS)
www.baseball-news-blog.com - September 6 at 8:11 AM
News IconStock in Review: Taking a Closer Look at Alkermes plc (NASDAQ:ALKS) Shares - Post News (NASDAQ:ALKS)
www.kentuckypostnews.com - September 1 at 3:25 PM
capitalcube.com logoETF’s with exposure to Alkermes Plc : August 25, 2016 (NASDAQ:ALKS)
www.capitalcube.com - August 25 at 3:28 PM
capitalcube.com logoAlkermes Plc breached its 50 day moving average in a Bullish Manner : ALKS-US : August 24, 2016 (NASDAQ:ALKS)
www.capitalcube.com - August 24 at 11:43 AM
investornewswire.com logoAlkermes plc (NASDAQ:ALKS) Gets 0 Recommendations To Sell - Investor Newswire (NASDAQ:ALKS)
www.investornewswire.com - August 23 at 3:26 PM
investornewswire.com logoCan Alkermes plc (NASDAQ:ALKS) Keep Up With Analyst Expectations? - Investor Newswire (NASDAQ:ALKS)
www.investornewswire.com - August 20 at 3:29 PM
benzinga.com logo11 Biopharma CEOs To Follow On Twitter (NASDAQ:ALKS)
www.benzinga.com - August 18 at 11:49 AM
investornewswire.com logoWill Alkermes plc (NASDAQ:ALKS) Hit $66 Price Target? - Investor Newswire (NASDAQ:ALKS)
www.investornewswire.com - August 16 at 3:27 PM
thestreet.com logoWant a Dash for Trash? Why Not Look at Alkermes (NASDAQ:ALKS)
realmoney.thestreet.com - August 15 at 10:41 AM
stocksdaily.net logoAlkermes plc (NASDAQ:ALKS) Ratings in Focus - Stocks Daily (NASDAQ:ALKS)
www.stocksdaily.net - August 13 at 3:25 PM
stocksdaily.net logoAlkermes plc (NASDAQ:ALKS) Ratings in Focus (NASDAQ:ALKS)
www.stocksdaily.net - August 13 at 11:36 AM
fidaily.com logoAlkermes plc (ALKS) Holdings Increased by Canada Pension Plan Investment Board - Finance Daily (NASDAQ:ALKS)
www.fidaily.com - August 11 at 3:28 PM
capitalcube.com logoAlkermes Plc breached its 50 day moving average in a Bearish Manner : ALKS-US : August 11, 2016 (NASDAQ:ALKS)
www.capitalcube.com - August 11 at 12:40 PM
ftsenews.co.uk logoNew Broker Ratings For Alkermes Plc (NASDAQ:ALKS) - FTSE ... - FTSE News (NASDAQ:ALKS)
www.ftsenews.co.uk - August 9 at 12:11 PM
streetupdates.com logoInvestors Spotlight: Stereotaxis, Inc. (NASDAQ:STXS) , Alkermes plc (NASDAQ:ALKS) - Street Updates (NASDAQ:ALKS)
www.streetupdates.com - August 9 at 12:11 PM
tradecalls.org logoJefferies Maintains Alkermes Plc to Buy with Price Target $62.00 - Trade Calls (NASDAQ:ALKS)
www.tradecalls.org - August 8 at 8:13 AM
tradecalls.org logoAlkermes plc (ALKS) Shares are Down -2.63% – Trade Calls - Trade Calls (NASDAQ:ALKS)
www.tradecalls.org - August 8 at 8:13 AM
streetinsider.com logoAlkermes plc (ALKS) Submits ARISTADA sNDA for Schizophrenia; Receives USPTO Notice of Allowance on Related ... - StreetInsider.com (NASDAQ:ALKS)
www.streetinsider.com - August 8 at 8:13 AM
finance.yahoo.com logo7:01 am Alkermes submits a sNDA to the FDA for a two-month dosing interval of ARISTADA extended-release injectable suspension for the treatment of schizophrenia; also announces USPTO issued a NOA for ARISTADA (NASDAQ:ALKS)
finance.yahoo.com - August 8 at 8:13 AM
publicnow.com logoAlkermes Submits Supplemental New Drug Application to FDA for Two-Month Dosing Option of ARISTADA® for Treatment of Schizophrenia (NASDAQ:ALKS)
www.publicnow.com - August 8 at 8:13 AM
capitalcube.com logoETF’s with exposure to Alkermes Plc : August 4, 2016 (NASDAQ:ALKS)
www.capitalcube.com - August 4 at 3:28 PM
capitalcube.com logoAlkermes Plc :ALKS-US: Earnings Analysis: Q2, 2016 By the Numbers : August 3, 2016 (NASDAQ:ALKS)
www.capitalcube.com - August 3 at 3:30 PM
finance.yahoo.com logoALKERMES PLC. Financials (NASDAQ:ALKS)
finance.yahoo.com - August 3 at 3:30 PM
live-pr.com logoNew Market Research Report: Alkermes Plc (ALKS) - Pharmaceuticals & Healthcare - Deals and Alliances Profile (NASDAQ:ALKS)
www.live-pr.com - August 1 at 3:26 PM
News IconComprehensive Report on: Alkermes plc (NASDAQ:ALKS), MEDNAX, Inc. (NYSE:MD) - News Oracle (NASDAQ:ALKS)
www.newsoracle.com - July 29 at 3:26 PM

Social

Alkermes PLC (NASDAQ:ALKS) Chart for Wednesday, September, 28, 2016


Last Updated on 9/28/2016 by MarketBeat.com Staff